Plasma Level-Effect Relationships for some Acute Cardiovascular Effects of Nisoldipine and Other Dihydropyridine Calcium Channel Antagonists

1987 ◽  
pp. 67-75 ◽  
Author(s):  
K.-H. Graefe ◽  
R. Ziegler ◽  
W. Wingender ◽  
K.-D. Rämsch ◽  
G. Ahr ◽  
...  
Keyword(s):  
Plasma Level ◽  
Calcium Channel ◽  
Cardiovascular Effects ◽  
Calcium Channel Antagonists ◽  
Level Effect

Cardiovascular Effects of Dihydropyridine Calcium Channel Antagonists and Their Relation to Drug Levels in Plasma

1988 ◽  
Vol 522 (1 Calcium Antag) ◽  
pp. 628-629 ◽  
Author(s):  
K.-H. GRAEFE ◽  
R. ZIEGLER ◽  
W. WINGENDER ◽  
K.-D. RÄMSCH ◽  
G. AHR
Keyword(s):  
Calcium Channel ◽  
Cardiovascular Effects ◽  
Calcium Channel Antagonists ◽  
Drug Levels

Crystal structure analysis of 4-R-phenyl-2,6-dimethyl-3,5-N-(dimethylcarbamoyl)-1,4-dihydropyridines [R=2-nitro (1), 4-methoxy (2) and 3,4-dichloro (3)]

1998 ◽  
Vol 213 (3) ◽  
Author(s):  
M. Bidya Sagar ◽  
K. Ravikumar ◽  
Y. S. Sadanandam
Keyword(s):  
Crystal Structure ◽  
Calcium Channel ◽  
Structure Analysis ◽  
Crystal Structure Analysis ◽  
Calcium Channel Antagonists

AbstractThe crystallographic characterization of the following three calcium channel antagonists is reported here: 2,6-dimethyl-3,5-dicarbamoyl-4-[2-nitro]-1,4-dihydropyridine (

ChemInform Abstract: Dimeric 1,4-Dihydropyridines as Calcium Channel Antagonists.

ChemInform ◽  
1989 ◽  
Vol 20 (4) ◽  
Author(s):  
A. F. JOSLYN ◽  
E. LUCHOWSKI ◽  
D. J. TRIGGLE
Keyword(s):  
Calcium Channel ◽  
Calcium Channel Antagonists
Sign in / Sign up

Export Citation Format

Share Document